Murai M - Search Results

1

Prognostic factors and predictive models in renal cell carcinoma: a contemporary review.

Sun M, Shariat SF, Cheng C, Ficarra V, Murai M, Oudard S, Pantuck AJ, Zigeuner R, Karakiewicz PI. Sun M, et al. Among authors: murai m. Eur Urol. 2011 Oct;60(4):644-61. doi: 10.1016/j.eururo.2011.06.041. Epub 2011 Jun 30. Eur Urol. 2011. PMID: 21741163 Review.

2

Tumour architecture is an independent predictor of outcomes after nephroureterectomy: a multi-institutional analysis of 1363 patients.

Remzi M, Haitel A, Margulis V, Karakiewicz P, Montorsi F, Kikuchi E, Zigeuner R, Weizer A, Bolenz C, Bensalah K, Suardi N, Raman JD, Lotan Y, Waldert M, Ng CK, Fernández M, Koppie TM, Ströbel P, Kabbani W, Murai M, Langner C, Roscigno M, Wheat J, Guo CC, Wood CG, Shariat SF. Remzi M, et al. Among authors: murai m. BJU Int. 2009 Feb;103(3):307-11. doi: 10.1111/j.1464-410X.2008.08003.x. Epub 2008 Oct 16. BJU Int. 2009. PMID: 18990163 Free article.

3

Activation of signal transducer and activator of transcription 3 in renal cell carcinoma: a study of incidence and its association with pathological features and clinical outcome.

Horiguchi A, Oya M, Shimada T, Uchida A, Marumo K, Murai M. Horiguchi A, et al. Among authors: murai m. J Urol. 2002 Aug;168(2):762-5. J Urol. 2002. PMID: 12131365

4

Elevated Akt activation and its impact on clinicopathological features of renal cell carcinoma.

Horiguchi A, Oya M, Uchida A, Marumo K, Murai M. Horiguchi A, et al. Among authors: murai m. J Urol. 2003 Feb;169(2):710-3. doi: 10.1097/01.ju.0000038952.59355.b2. J Urol. 2003. PMID: 12544348

5

Editorial comment on: impact of gender in renal cell carcinoma: an analysis of the SEER database.

Murai M. Murai M. Eur Urol. 2008 Jul;54(1):140-1. doi: 10.1016/j.eururo.2007.12.002. Epub 2007 Dec 17. Eur Urol. 2008. PMID: 18160208 No abstract available.

6

The prediction of renal function 6 years after unilateral nephrectomy using preoperative risk factors.

Ito K, Nakashima J, Hanawa Y, Oya M, Ohigashi T, Marumo K, Murai M. Ito K, et al. Among authors: murai m. J Urol. 2004 Jan;171(1):120-5. doi: 10.1097/01.ju.0000100981.11470.2f. J Urol. 2004. PMID: 14665858

7

Differential expression of activator protein-2 isoforms in renal cell carcinoma.

Oya M, Mikami S, Mizuno R, Miyajima A, Horiguchi Y, Nakashima J, Marumo K, Mukai M, Murai M. Oya M, et al. Among authors: murai m. Urology. 2004 Jul;64(1):162-7. doi: 10.1016/j.urology.2004.02.022. Urology. 2004. PMID: 15245963

8

C-jun activation in acquired cystic kidney disease and renal cell carcinoma.

Oya M, Mikami S, Mizuno R, Marumo K, Mukai M, Murai M. Oya M, et al. Among authors: murai m. J Urol. 2005 Aug;174(2):726. doi: 10.1097/01.ju.0000164656.99251.77. J Urol. 2005. PMID: 16006965

9

Renal cell carcinoma: relevance of pathology.

Oya M, Murai M. Oya M, et al. Among authors: murai m. Curr Opin Urol. 2003 Nov;13(6):445-9. doi: 10.1097/00042307-200311000-00004. Curr Opin Urol. 2003. PMID: 14560136 Review.

10

Human lymphoblastoid interferon therapy for advanced renal cell carcinoma.

Marumo K, Murai M, Hayakawa M, Tazaki H. Marumo K, et al. Among authors: murai m. Urology. 1984 Dec;24(6):567-71. doi: 10.1016/0090-4295(84)90103-1. Urology. 1984. PMID: 6506397

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

780 results

Search Page